dacarbazine and Lymphoma, T Cell, Peripheral

dacarbazine has been researched along with Lymphoma, T Cell, Peripheral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Eghbali, H; Foussard, C; Gressin, R; Jaubert, J; Lamy, T; le Gouill, S; Lucas, V; Maloisel, F; Milpied, N; Peoch, M; Rossi, JF; Simon, A; Thyss, A; Tournilhac, O; Vilque, JP	1

Trials

1 trial(s) available for dacarbazine and Lymphoma, T Cell, Peripheral

Article	Year
Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. British journal of haematology, 2010, Volume: 151, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult	2010

Article

Year

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95.

British journal of haematology, 2010, Volume: 151, Issue:2

Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2010